Intrinsic Value of S&P & Nasdaq Contact Us

Merus N.V. MRUS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • NL • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$110.00
+22.2%

Stock Statistics — MRUS

Merus N.V. (MRUS) has a market capitalization of $6.83B and trades at $90.00. The 52-week range is 33.19-97.14.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -26.9, Earnings Per Share (EPS) of $-3.35, annual revenue of $36.13M.

The stock has a beta of 1.06, operates in the Healthcare sector.

Trading Data
Current Price$90.00
52-Week Range33.19-97.14
Volume2.72M
Avg Volume (30D)1.72M
Market Cap$6.83B
Beta (1Y)1.06
Company
IPO Date2016-05-19
Employees260
CEOJan van de Winkel
CountryNL
ExchangeNASDAQ Global Market
CurrencyUSD
ISINNL0011606264
CUSIPN5749R100
Income (Latest Year)
Revenue$36.13M
Gross Profit$36.13M
EBITDA$-269.6M
Operating Income$-272.07M
Net Income$-215.33M
EPS$-3.35
EPS Diluted$-3.35
Shares Outstanding$64.22M
Balance Sheet (Latest Year)
Total Assets$785.13M
Current Assets$569.07M
Cash & ST Investments$537.03M
Total Liabilities$134.77M
Total Debt$9.91M
Net Debt$-283.38M
Total Equity$647.93M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-26.9
P/S Ratio188.91
P/B Ratio10.53
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message